ADIPOQ and systemic sclerosis: Our meta-analysis of observational, case–control studies in European populations supports the finding of lower circulating levels of adiponectin in patients with SSc compared to controls, with this reduction being more pronounced in the dcSSc subtype than in lcSSc, although both subtypes showed a similar association trend.